Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        EC-313 by Evestra for Endometriosis: Likelihood of Approval
EC-313 is under clinical development by Evestra and currently in Phase I for Endometriosis. According to GlobalData, Phase I drugs...
                                                Data Insights
                                                
                                        EC-313 by Evestra for Unspecified Gynecological Disorders: Likelihood of Approval
EC-313 is under clinical development by Evestra and currently in Phase I for Unspecified Gynecological Disorders. According to GlobalData, Phase...
